This Conference is closed. Compounding Pharmacy - Key Concepts in Microbiological Quality Control - Option 2 is organized by Parenteral Drug Association (PDA) and will be held on Jun 05, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments: Quality Control, Quality Assurance, Quality Systems, Technical Operations, Training Roles: Pharmacist, Auditor, Analyst, Microbiologist, Virologist, Supervisor, Manager Accreditation: CEUs: 0.6 Continuing Education for Professional Engineers: New Jersey: The credit value of this course is 6 CPC credits. North Carolina: The credit value of this course is 6 PDH credits. Description: Many of the regulations for compounding pharmacies have changed over recent years, with resulting requirements looking more like those applied to pharmaceutical manufacturing. As expectations have evolved so quickly for compounders, there has been a concordant need to quickly learn about new expectations and be prepared to put those into place for day-to-day practice. This training course will help close the knowledge gap about how compounders should be performing their microbiological QC testing, as well as control measures that should be implemented to contribute toward sterility assurance of products. Objectives: • Explain the importance of testing in the overall quality program in the compounding facility • Assess when and what to test when considering microbiological quality of product • Evaluate appropriate methods and equipment to use in microbiological QC testing • Review and interpret micro QC results to examine whether the compounded product is safe and the compounding process and facility is performing as expected • Examine current regulations and how they should be appropriately applied in different compounding settings

Rare of the Rare Summit is organized by Immune Deficiency Foundation (IDF) and will be held from Aug 28 - 30, 2020 at Bethesda Marriott, Bethesda, Maryland, United States of America. Description: Rare of the Rare is an opportunity for those affected by the rarest forms of PI to meet with NIH experts, learn about new research and therapies, and meet others who share similar experiences. Featured sessions will include clinical trial information, family-centered programming, a focus on YOU as the expert, targeted breakouts, and information on the state of treatment and therapy. Your feedback about unmet needs in these communities will help guide future programming from IDF. The summit is designed for those with phagocytic and complement disorders as well as t-cell and combined deficiencies including: • Chronic Granulomatous Disease (CGD) • Complete DiGeorge Anomaly (CDGA) • Good’s Syndrome (GS) • Hemophagocytic Lymphohistiocytosis (HLH) • Hyper IgE Syndrome/JOB Syndrome • Hyper IgM Syndrome (HIgM) • Leukocyte Adhesion Deficiencies (LAD) 1 & 2 • Natural Killer (NK) Cell Deficiency • NEMO Deficiency Syndrome • Severe Combined Immunodeficiency (SCID) • WHIM (warts, hypogammaglobulinemia, infections and myelokathexis) Syndrome • Wiskott-Aldrich Syndrome (WAS) Additional details will be posted as soon as information is available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Sep 11, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

2020 Melorheostosis Conference is Organized by Melorheostosis Association and will be held from Oct 23 - 25, 2020 at Bethesda Marriott Suites, Bethesda, Maryland, United States of America. Additional details will be posted as soon as information is available.

2024 ACCP Annual Meeting is organized by American College of Clinical Pharmacology (ACCP) Annual Meeting and will be held from Sep 08 - 10, 2024 at Bethesda North Marriott Hotel & Conference Center, Bethesda, Maryland, United States of America.  Additional details will be posted as soon as they are available.